Caladrius Biosciences CEO David Mazzo's 2020 pay slips 7% to $1.4M
Caladrius Biosciences reports 2020 executive compensation
By ExecPay News
Published: April 28, 2021
Caladrius Biosciences reported fiscal year 2020 executive compensation information on April 28, 2021.
In 2020, five executives at Caladrius Biosciences received on average a compensation package of $740K, a 11% decrease compared to previous year.
Average pay of disclosed executives at Caladrius Biosciences
David J. Mazzo, Chief Executive Officer, received $1.4M in total, which decreased by 7% compared to 2019. 43% of Mazzo's compensation, or $613K, was in salary. Mazzo also received $330K in bonus, $226K in option awards, $236K in stock awards, as well as $30K in other compensation.
Douglas Losordo, Chief Medical Officer, received a compensation package of $713K, which decreased by 20% compared to previous year. 58% of the compensation package, or $412K, was in salary.
Todd Girolamo, General Counsel, earned $655K in 2020, which is about the same as previous year.
Joseph Talamo, Chief Financial Officer, received $495K in 2020, which decreases by 27% compared to 2019.
William K. Sietsema, Vice President, Global Regulatory Affairs, earned $400K in 2020, a 3% increase compared to previous year.
Related executives
David Mazzo
Caladrius Biosciences
Chief Executive Officer
Douglas Losordo
Caladrius Biosciences
Chief Medical Officer
Joseph Talamo
Caladrius Biosciences
Chief Financial Officer
Todd Girolamo
Caladrius Biosciences
General Counsel
William Sietsema
Caladrius Biosciences
Vice President, Global Regulatory Affairs
You may also like
Source: SEC filing on April 28, 2021.